BridgeMD
New treatment option for Adhesive Capsulitis
Official title Effects of Gong's Mobilization With and Without Nielasher Technique on in Adhesive Capsulitis
ClinicalTrials.gov ID: NCT07628335
What this study is testing
- What it's testing
- Adhesive Capsulitis causes a progressive tightening of the glenohumeral joint capsule, restricting both active and passive movements and resulting in functional impairments. Joint mobilization is an essential component of physical therapy for managing adhesive capsulitis.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 60. Healthy volunteers may be eligible.
You may be able to join if
- Individuals with age group of 40-60 years.
- Both Females and males individuals.
- Individuals diagnosed with Frozen shoulder (Adhesive Capsulitis) within stage II and III of frozen shoulder.
- Individuals with positive capsular pattern (ER\>Abd\> IR).
- Individuals with ROM loss ≥ 25% in at least two planes compared with the noninvolved shoulder
You likely can't join if
- Individuals with rotator cuff tears and overuse injury
- Individuals with inflammatory diseases (Osteoarthritis, Rheumatoid Arthritis, Gout) and Malignancies
- Individuals Using Corticosteroid Injections or Medications
The study team makes the final eligibility decision.
Where it's taking place
- Lahore, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 60 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lahore, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.